Regeneron (REGN) Highlights Positive Topline Results in Phase 3 Trial
Go back to Regeneron (REGN) Highlights Positive Topline Results in Phase 3 Trial| Regeneron (NASDAQ: REGN) | Delayed: 612.14 +0.66 (0.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $611.48 | 52 Week High | $592.36 | |||
| Open | $613.11 | 52 Week Low | $325.35 | |||
| Day High | $616.55 | P/E | 160.67 | |||
| Day Low | $605.01 | EPS | $3.81 | |||
| Volume | 717,681 | |||||
| SANOFI (NASDAQ: SNY) | Delayed: 44.25 +0.14 (0.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $44.11 | 52 Week High | $44.76 | |||
| Open | $44.11 | 52 Week Low | $36.81 | |||
| Day High | $44.51 | P/E | N/A | |||
| Day Low | $44.02 | EPS | $0.00 | |||
| Volume | 1,633,184 | |||||

